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Abstract: High levels (> 200 µg/L) of inorganic arsenic in drinking water are known to be a
cause of human lung cancer, but the evidence at lower levels is uncertain. We have sought the
epidemiological studies that have examined the dose-response relationship between arsenic levels
in drinking water and the risk of lung cancer over a range that includes both high and low
levels of arsenic. Regression analysis, based on six studies identified from an electronic search,
examined the relationship between the log of the relative risk and the log of the arsenic exposure
over a range of 1–1000 µg/L. The best-fitting continuous meta-regression model was sought and
found to be a no-constant linear-quadratic analysis where both the risk and the exposure had been
logarithmically transformed. This yielded both a statistically significant positive coefficient for the
quadratic term and a statistically significant negative coefficient for the linear term. Sub-analyses by
study design yielded results that were similar for both ecological studies and non-ecological studies.
Statistically significant X-intercepts consistently found no increased level of risk at approximately
100–150 µg/L arsenic.
Keywords: arsenic; lung cancer; drinking water; dose-response; risk analysis

1. Introduction
Inorganic arsenic in drinking water occurs naturally from the earth’s crust and anthropogenically
as a byproduct of some industrial processes and uses. While human arsenic exposure can be air-borne
or food-borne (generally organic arsenic), the biggest cancer health threat from inorganic arsenic in
the environment is from drinking water [1]. Organic arsenic compounds, which are abundant in
seafood, are less harmful to health and are rapidly eliminated by the body [1].
Exposure to inorganic arsenic through drinking water causes bladder, skin, and lung cancers and
has been classified as being carcinogenic to humans by the International Agency for Research against
Cancer [2] and as a known human carcinogen by the U.S. Environmental Protection Agency [3].
Int. J. Environ. Res. Public Health 2015, 12, 15498–15515; doi:10.3390/ijerph121214990
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Multiple studies around the world have demonstrated the increased risk of bladder and lung cancers
with exposure to drinking water containing high levels of inorganic arsenic. The studies from
Taiwan [4–6] and Chile [7–9] have received the most attention. Additional non-USA studies include
those from Argentina [10,11], Bangladesh [12] and Japan [13]. Previous systematic reviews of lung
cancer and ingested arsenic exposure have pointed out the significant associations between lung
cancer and high arsenic exposures [14,15].
Lung cancer risk from exposures to arsenic in the hundreds of µg/L range but not below
100 µg/L has been consistently found. The dose-response pattern transitioning from relatively low
risk at low exposure levels to high risks at high exposure levels is unknown. The purpose of this
analysis is to examine across this low to high concentration range. The dose-response patterns might
be evident in the assembly of the data while not otherwise evident in the examination of single
studies. Furthermore, we additionally wish to examine whether such patterns are consistent across
study designs.
We have assembled the published literature on lung cancer and drinking water arsenic levels and
examined the risk over the spectrum of exposure—from about 1 ppb (1 µg/L) to 1 ppm (1000 µg/L).
This range was chosen since some publications have suggested that there is a carcinogenic threshold
in the 100 µg/L to 200 µg/L range [16,17]. Such a threshold would be consistent with the more recent
toxicological/Mode of Action (MOA) findings of arsenic exposure initially inducing a cellular toxicity
that leads secondarily to a cellular proliferation. This proliferation then promotes the growth of
induced or endogenous mutations, which subsequently lead to additional cancer [16,18,19]. We shall
examine the epidemiological literature to identify the dose-response pattern over this exposure range.
2. Materials and Methods
2.1. Source Material
A search of electronic literature bases (PubMed [N = 92], Embase [N = 165], Web of Science
[N = 26], and Scopus [N = 14]) was conducted in August 2015 using the keywords “drinking water
arsenic”, “lung cancer”, and “epidemiology”. There was no restriction on geography or on language.
This yielded 202 citations from 1981 through 2015. Their titles and/or abstracts were reviewed.
Reviews were examined to identify primary studies that might have been missed. Subsequent
analyses of previously published studies were also sought. The preliminary search was for studies
with risk estimates at various exposure levels including low exposures. The selection was then
restricted to studies that reported lung cancer risks in a defined study population of males and
females combined, used drinking water arsenic level in units of µg/L as the exposure metric, and
had both a reference population with lung cancer at low arsenic exposure as well as additional study
populations at both low and high arsenic exposure with high exposure being defined here as greater
than 100 µg/L. The most recent data presentations for each study were used in our analyses [20,21].
2.2. Study Populations
The search sought ecological, case-control, and cohort studies and was updated on 13 August
2015. There was no restriction on country of study or language of publication. We used the study
populations as defined by the authors. All studies had been designed to assess the relationship
between drinking water arsenic level and lung cancer incidence or mortality. Incidence cases came
either from local and national cancer registries, or hospital records. Mortality cases came from vital
statistics records at the national, state, or local level.
2.3. Exposure
All exposure measurements are for arsenic (As) water concentration given in micrograms arsenic
per liter (ug As/L) drinking water, equivalent to parts per billion (ppb). Exposures are expressed as
either mean or population-weighted mean where feasible; otherwise, mid-range or highest exposures
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were used. Arsenic exposure data were log-transformed to log arsenic (Log As) as the exposure metric
for analyses of individual studies since the exposure range covered three orders of magnitude. In the
meta-regression analysis, the exposure metric was transformed to Log [(As ´ Ref) +1] due to the
requirements of the analysis, where As was the arsenic water concentration for the study population
in the particular study and Ref was the arsenic water concentration (µg/L) for the reference group in
the particular study.
2.4. Outcome Metric
Studies produced outcomes of lung cancer risk as standardized mortality ratios (SMR) in
ecological studies, odds ratios (OR) in case-control studies, and incidence relative risks (RR) in a
cohort study. Relative risks or risk ratios were developed for the ecological studies using the SMR
in the lowest exposure group as the reference risk and presented as the ratio of the SMR in the
specific exposure strata to the SMR in the reference exposure strata. Similarly, the risk ratios for
the case-control and cohort studies used the odds ratios or adjusted relative risks with the lowest
exposure group as the reference risk.
2.5. Analysis
For each individual study, the data were displayed on a scatter plot with log risk ratio (Log RR)
as the dependent variable and log arsenic (Log As) as the independent variable. A visual examination
revealed a non-linear pattern with an upward curve at higher exposure levels. A variety of non-linear
models (polynomial through cubic, logistic, exponential, and power models) were examined for
their fits to the data with the most consistent pattern seen for a linear-quadratic model. The AIC
goodness-of-fit was used to assist in model selection. Each study population was examined for
a goodness-of-fit to a linear-quadratic regression model performed in Microsoft Excel [22] with a
p (p-value) for the model at a two-tailed significance level of 5%. Log Arsenic is retained as the
expression of exposure rather than Arsenic, as the AIC goodness-of-fit statistic in the all studies model
was smaller when Log Arsenic was used (´0.468) than when Arsenic was used (´0.248).
For a pooled regression analysis, the data from all studies were similarly displayed. A
linear-quadratic regression model was performed utilizing each data point from each study
population in the analysis for all studies. For the pooled regression analyses by study design, the
data were limited to those of the studies meeting that specific study design. Log of the risk ratio
(Log RR) was the dependent variable, and log arsenic (Log As) was the independent variable in the
regressions performed, yielding a set of coefficients with a p-value for each of the coefficients where
a two-tailed significance level is set at 5%.
Models were examined for their statistical significance (Prob > F values) and for the coefficients
of the linear and quadratic terms with their statistical significance. Where the constant term was not
statistically significant, the regressions were run in a no-constant model.
For the meta-regression analyses, the data were organized by study and analyzed using a
linear-quadratic meta-regression model as a series of subsets of data, one set for each study.
Meta-regression analyses were conducted using the “metareg” function in STATA, 13.2 [23]. The data
points belonging to a specific study population were not themselves independent but did comprise
separate data sets that were analyzed as groups. The uncertainty in the risk estimate of each data
point was essentially a reflection of its number of cases and those in the reference point for that study
population. Analyses were conducted for all studies together and for each study design.
The independent (exposure) variable was transformed to log [(As ´ Ref) + 1] in order to examine
the pattern of the change in risk as the exposure level increased above the reference exposure level.
The (As ´ Ref) in the transformation accommodates the differences in reference levels among the
studies and provided a common starting point, and the (+1) in the transformation accommodated for
the exposure variable being a logarithmic function and for the fact that log (zero) would be undefined.
The net effect of the transformation was that each model began at the starting point of no increased
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lung cancer risk at no increased arsenic exposure, i.e., not above the reference level. Thus, at arsenic
(As ´ Ref) = 0 µg/L, log [(As ´ Ref) + 1] is log (1) or zero on the logarithmic scale. The reference
point waszeroed out, and, when the constant term in the regression was not significant, a no-constant
model was run.
We conducted a random effects meta-regression model that addressed these aspects, written as
Eq. 1

´
¯
´
¯
Log RRi “ β 1 LA2i ` β 2 LAi ` µi ` ei , where µi „ N 0, τ 2 and ei „ N 0, σi2 ,

where Log RRi is log-relative risk, and LAi is log [(arsenic ´ reference) +1] level in study i,
respectively. The random effect µi is the study ith specific randomness that varies between studies.
Here τ 2 accounts for between-study variance, where a smaller value of τ 2 implies more homogeneous
outcome-covariates associations across studies. The quadratic term is retained according to the
smaller AIC goodness-of-fit statistics (´0.466) compared to that of the linear model (´0.295) in
all types of studies. The inclusion of a cubic term did not improve the goodness-of-fit. p-values
for the coefficients of the linear and quadratic term coefficients were obtained, as were p-values
(p > F) from the joint test of the null hypothesis, i.e., that the coefficients of β 1 and β 2 are equal
to zero after the Knapp-Hartung modification of standard errors [24]. The heterogeneity measures
2 and between study variance τ 2 were also computed [25]. Meta-regression was performed
Ires
using “metareg” function in STATA. For each model, where the linear coefficient was negative, and
where the quadratic coefficient was positive, the Xintercept , the point at which increased risk is zero
(i.e., Relative Risk = 1.0), was calculated as the antilog of the ratio of the coefficients
(´linear/quadratic) and is quite similar to the no-increase risk level for the data.
3. Results
3.1. Literature Search
The initial search identified 20 studies for consideration, six of which met the specific study
parameters. Four studies were excluded because the exposure media were not drinking water arsenic
levels—soil or sediment [26], toenails [27], urine [28], or air [29]. Three studies were excluded because
the drinking water arsenic metric was not expressed as µg/L—cumulative exposure [30] or well water
arsenic level distributions [31,32]. Two studies were excluded because of outcome measures—no lung
cancer in reference population [12] or outcome was a slope rather that a risk ratio [33]. Four studies
were excluded because their highest exposure level was in the low exposure range at 10 µg/L [34],
7.58 µg/L [35], 26.5 µg/L [36], and 60 µg/L [37]. One study was excluded because information
was incomplete with different exposure intervals for males and for females and no case or control
information for non-smoking females [12]. Finally, the Argentinian lung cancer study was excluded
because of exposure uncertainty, as its well water measurements were from the 1930s when the assay
had a limit of detection of 40 µg/L [11]. In contrast, the other studies used a later assay with a limit
of detection of 10 µg/L or lower. A total of six studies met the inclusion criteria.
3.2. Study Populations
These 6 studies included three studies from Chile [20,38,39], two studies from Taiwan [21,40],
and one study from the United States [41]. These consisted of two ecological studies [38,40], three
case-control studies [20,39,41], and one cohort study [21]. The two ecological studies were mortality
studies with standardized mortality ratios (SMRs) as the expression of risk. The three case-control
studies were incidence studies with odds ratios (ORs) or adjusted odds ratios as the expression of
risk, and the single cohort study was an incidence study with adjusted relative risks.
The data from the six studies were analyzed as six study populations with males and females
combined. Ferreccio et al. (2006) [38] reported analyses for four locations and for two time periods
(1985–1992 and 1993–2002). The data for the two contiguous time periods were combined into a
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single data set for each location for the purposes of this analysis. All of the studies were restricted
to adults, defined here as ranging from ě 20 year-old(Morales et al., 2000) [40] to ě 40 year-old
(Bogen et al., 2014) [21] with the exception of Ferreccio et al. (2006) [38], which appears to be for the
full population. Since lung cancer prior to age 20 is a rare event, it is unlikely to affect the analysis.
With the exception of Morales et al. (2000) [40], the studies did not provide the opportunity to analyze
male and female data separately. The critical information for each of these studies in the analysis is
in Table 1 and organized by study design. Details of the individual studies and the derivations of
their exposure estimates and risk ratios are presented in Appendix A. Each of these studies has data
from three or more exposure levels, as recommended by the National Research Council (2013) [42]
for dose-response analyses for inorganic arsenic.
Table 1. Studies with characteristics and data.
Author

Location

Ecological Studies
Ferreccio 2006
Chile

Morales 2000

Southwest
Taiwan

Non-Ecological Studies
Case-Control Studies
California &
Dauphine 2013
Nevada, USA

Exposure
(µg/L)

Relative
Risk

Highest

<10
287
636
860

1.00 (ref)
0.93
3.51
3.08

Pop-Wt. Mean

33.1

1.00 (ref)

66.3
115.2
246.3
336.3
446.7
524.4
693.9

0.82
0.91
2.28
1.3
2.4
2.03
3.11

ď10

1.00 (ref)

42.5
173
10.2
60
377.5
860

0.75
0.84
1.00 (ref)
0.77
1.38
2.39

1

1.00 (ref)

12.8
154
636
600
860

0.7
3.4
4.7
5.7
7.1

1

1.00 (ref)

3.26
25.9
74.3
160
711

0.57
0.73
0.68
1.08
1.57

Period

Outcome

Exposure Metric

1985–2002

Mortality

1973–1986

Mortality

2002–2005

Incidence

Mid-Range; Mean

Ferreccio 2013

Chile

2007–2010

Incidence

Pop-Wt. Mean

Smith 2009
(Ferreccio 2000)

Chile

1994–1996

Incidence

Pop-Wt. Mean

Cohort Study
Bogen 2014
(Chen 2010)

Northeast
Taiwan

1991–1994

Incidence

Mean

3.3. Exposure Metrics
The arsenic exposure levels for each of the studies are expressed in µg/L (ppb) and for the
most part presented in the published studies as exposure ranges [41], mean [21], or highest
exposure [38]. Population-weighted means were calculated where population numbers for strata
within the exposure ranges were given [20,39,40]. In the Chilean studies, each area was assigned
its highest known arsenic level: Antofagasta and Meijillons (860 µg/L). Tocopilla and Maria Elena
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(636 µg/L rather than 250 µg/L), and Calama (287 µg/L rather than 150 µg/L), were analogous to
that used in Ferreccio et al. (2013) [39]. The exposure data for the Southwest Taiwan ecological study,
from which mean village well water arsenic levels were developed, were published by the National
Research Council (1999) [43].
Smoking is the only other significant exposure for lung cancer. Three studies provided
smoking-adjusted results across the arsenic exposure spectrum [20,21,41], and one study had
information for only the extremes of the arsenic exposure spectrum [39]. No information on smoking
was given in ecological studies [38,40]. None of the studies provided data that enabled distinguishing
between risks in smokers and risks in non-smokers.
3.4. Outcome
Lung cancer cases were identified by the original authors from national or local cancer
registries [21,41], from national or local death registries [38,40], or from physician or hospital
contacts [20,39]. Controls for case-control studies were obtained from random digit dialing [41],
from random selections from electoral registry [38], or from frequency-matched hospital and cancer
patients [20].
Relative risks or risk ratios were utilized in the analyses with the lowest exposure group
serving as the reference group. Risk ratios for the ecological studies were calculated using the SMRs
(standardized mortality ratios) for each exposure strata [20,38]. Risk ratios for the case-control studies
used the odds ratios or adjusted odds ratios for each exposure strata [20,39,41]. Risk ratios for the
cohort study used the adjusted relative risks for each exposure strata from the study [21].
3.5. Study Design
Study designs separate into ecological studies in which information on cases and comparisons
are known on a group basis, such as the number of deaths or cases in a certain age interval and time
period in geographic areas with known arsenic exposure levels, but without specific information on
individual cases. The non-ecological studies—case-control or cohort—are distinct from the ecological
studies in that they contain specific information such as smoking history on individual subjects, often
obtained by interview.
3.6. Dose-Response Analysis
3.6.1. Single Studies
The data from each study have been visually displayed in log RR vs. log As scattergrams and
analyzed with a linear-quadratic regression model (Figure 1). The data approximate a good visual
fit to the model in each of the studies. Three study populations showed a statistically significant
goodness of fit (Prob>F value) for the linear-quadratic model. These three were the SW Taiwan
ecological study [40] and the two Chilean case-control studies [20,38]. The quadratic term was
significant in two analyses [21,39]. The intercept term was significant only in the analysis of the
Ferreccio et al. (2013) [39] study.
Five of the six studies only presented combined data for males and females together. In the one
study for which data for males and females could be analyzed separately, the results for the males
(y = 0.37x2 – 1.18x + 0.86; p = 0.05) and for the females (y = 0.45x2 – 1.60x + 1.43; p = 0.04) were quite
similar to each other and to that with the data combined (y = 0.37x2 ´ 1.23x + 0.97; p = 0.02) [40].
This circumstance of multiple studies appearing to show a similar regression pattern, although
not all with a statistically significantly fit, is an appropriate opportunity for pooled analyses and for
meta-regression analyses.
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Figure
plots
of of
individual
studies.
* Ecological
Studies:
Ferrecio
et al., et
2006
(Chile),
Figure1.1.Log-Log
Log-Log
plots
individual
studies.
* Ecological
Studies:
Ferrecio
al.,[38]
2006
[38]
Morales et al., 2000 [40] (SW Taiwan); ‰ Case-Control
Studies:
Ferrecio
et
al.,
2013
[39]
(Chile),
(Chile), Morales et al., 2000 [40] (SW Taiwan); ǂ Case-Control Studies: Ferrecio et al., 2013
Dauphine et al., 2013 [41] (USA), Smith et al., 2009 [20] (Chile), Cohort Study: Bogen et al., 2014 [21]
[39]Taiwan).
(Chile), Note:
Dauphine
al.,
(NE
log 1 et
= 0;
log2013
10 = [41]
1; log(USA),
100 = 2.Smith et al., 2009 [20] (Chile), Cohort Study:

Bogen et al., 2014 [21] (NE Taiwan). Note: log 1 = 0; log 10 = 1; log 100 = 2.

3.6.2. Pooled Analysis
The study base consists of the studies (N = 6) and their data points (n = 31). Each data point is
defined by a log RR value and a log Arsenic value. Figure 2 presents a display of the pooled data
from the six studies with linear-quadratic regression models for all the data and for each subset of
data organized by study design. The models with their analytic results are shown for the six study
data sets and for sub-sets based on study design—Ecological (N = 2; n = 12) and Non-Ecological
(N = 4; n = 19); Case-control (N = 3; n = 13) and Cohort (N = 1; n = 6). There is an excellent (p < 0.0005)
fit in most of the analyses and a good (p < 0.04) fit in the cohort analysis.
The analyses were first run with a constant term. However, as the constant term had been
non-significant in each of the analyses, the analyses were subsequently run without the constant term.
All regression models show a similar pseudo-parabolic pattern. In each analysis, the quadratic term is
positive and always statistically significant, and the linear term is negative and (with one exception)
statistically significant. The exception is for the linear term of the analysis of the case-control studies,
where the p-value was 0.051 rather than < 0.05.
The regression lines for each of the study design groups display in Figure 2 the same pattern
as those of all studies. All have statistically significant positive coefficients for the quadratic term
with statistically (or nearly) significant negative coefficients for the linear term. All have a strong
outcome-covariate association (p < 0.0005) for the model, with the exception of the cohort analysis,
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which shows a good outcome-covariate association (p = 0.04) for the model. Most interesting is that
the linear-quadratic regression models for the ecological and non-ecological studies are remarkably
similar.
single
cohort
study
yielded
model that is somewhat deeper than the others.
Int. J. The
Environ.
Res.
Public
Health
2015,a12
10

Regression Analysis by Study Design
(Log RR vs. Log Arsenic )
1.00
0.80

Log Relative Risk

0.60

All = 0.173x2 - 0.327x P < 0.0001
Ecol = 0.158x2 - 0.302x P = 0.0001

All

0.183x2

- 0.341x P < 0.0001
Non-Ecol =
Case/Cont = 0.177x2 - 0.299x P < 0.0005
Cohort = 0.149x2 - 0.345x P = 0.0402

Ecol
Non-Ecol
Case/Cont

0.40

Cohort
Poly. (All)

0.20

Poly. (Ecol)
0.00
0.0000

0.5000

1.0000

1.5000

2.0000

2.5000

3.0000

3.5000

Poly. (Non-Ecol)
Poly. (Case/Cont)

-0.20

Poly. (Cohort)
-0.40
Log Arsenic (µg/L)

Figure2.
2. Log
Log relative risk
Figure
risk by
bylog
logarsenic
arsenicfor
forallallstudy
studydesigns.
designs.

regression lines for each of the study design groups display in Figure 2 the same pattern as those
3.6.3. The
Meta-Regression
of all studies. All have statistically significant positive coefficients for the quadratic term with
The above analyses have demonstrated the results of pooling the data points within the various
statistically (or nearly) significant negative coefficients for the linear term. All have a strong
studies in order to ascertain the dose-response relationship over the exposure range of observation.
outcome-covariate
association
(pare
< 0.0005)
for the model,
exception
of the cohort
analysis,
Intrinsic
to this analytic
method
the assumptions
thatwith
eachthe
data
point carries
the same
weight
which
shows
a
good
outcome-covariate
association
(p
=
0.04)
for
the
model.
Most
interesting
is
that
the
and that each data point is independent of the others. As the data do not fulfill these assumptions,
linear-quadratic
regression
models
for
the
ecological
and
non-ecological
studies
are
remarkably
similar.
meta-regression analyses (Table 2) have been conducted to address these issues.
The
single
cohort study yielded
a model
that is
somewhat
than
others.
The
meta-regression
analysis
takes into
account
the deeper
variance
ofthe
each
data point by the inclusion
of a standard error term based on the number of cases and their comparisons. It further maintains the
3.6.3.
Meta-Regression
study
source
of each data point as a linked set of data.
The desire of an analytic model should include that there is no increased lung cancer risk at
The above analyses have demonstrated the results of pooling the data points within the various studies
zero additional arsenic exposure. As described, we have transformed the exposure measure from
in order to ascertain the dose-response relationship over the exposure range of observation. Intrinsic to
log Arsenic to log (As ´ Ref + 1). The abscissa intends to express the increased exposure above the
this analytic
are of
thethe
assumptions
that eachlevels.
data point
carries
same weight
that each
data
reference
levelmethod
for each
study exposure
Thus,
the the
adjustment
(Asand
´ Ref)
takes
into
point
is
independent
of
the
others.
As
the
data
do
not
fulfill
these
assumptions,
meta-regression
analyses
consideration that different studies have different reference exposure levels and moves each study to
have been
conducted
to addressexposure
these issues.
the(Table
same 2)
starting
point
of no increased
above the reference level or zero. However, since
The
analysis
takes into
account the
of each
data from
point by
of alog
the log
ofmeta-regression
zero is undefined,
we have
transformed
thevariance
exposure
variable
logthe
(Asinclusion
´ Ref) to
standard
based
on the
cases [(As
and their
comparisons.
It further
maintains
[(As
´ Ref)error
+ 1] term
so that,
when
(Asnumber
´ Ref) of
is zero,
´ Ref)
+ 1] is 1 and
log [(As
´ Ref) +the
1] study
is zero.
Thus,
theof
model
begins
at as
noaincreased
cancer risk and at no increased arsenic exposure level.
source
each data
point
linked set lung
of data.
The desire of an analytic model should include that there is no increased lung cancer risk at zero
additional arsenic exposure. As described, we have transformed the exposure measure from log Arsenic
to log (As − Ref + 1). The abscissa intends to express the increased exposure above the reference level
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Table 2. Meta-regression results by study design.
(As ´ Ref) +1

No

β Quadratic

p-Quadratic *

β Linear

p-Linear *

Prob > F

Xintercept

All
Ecological
Non-Ecological
Case-Control
Cohort +

25
10
15
10
5

0.2139
0.2442
0.1833
0.1892
0.1488

0.000
0.029
0.013
0.050
0.022

´0.4564
´0.5378
´0.3796
´0.3766
´0.3445

0.002
0.065
0.034
0.113
0.023

0.000
0.001
0.009
0.022
0.049

136.2
159.4
117.7
97.9
206.9

O

Number of data points. * p-quadratic and p-linear refer to the p-values of the quadratic and linear terms,
respectively. + The cohort results are from a simple regression rather than a meta-regression, as there is only
one cohort study.

The meta-regression analyses (Eq. 1) reveal that the data, after controlling for study population
and including the uncertainty estimate of the log RR [SE (Log RR)], yield an excellent fit (p > F) to
the no-constant linear-quadratic regression model for all study populations, for study populations
from ecological studies, and for study populations from non-ecological studies. Additionally, the
data yield a good fit for study populations from the case-control studies and from the cohort study.
The regression for the cohort study is a simple no-constant linear-quadratic regression model, as a
random effect analysis, would have no meaning for a single study.
The primary model, which included all study populations and all study designs, yielded a
quadratic term (~0.21) with a statistically significant positive coefficient and a linear term (~0.46)
with a statistically significant negative coefficient. Sub-analyses were conducted by study design.
The sub-analyses for study populations in ecological studies and for study populations in
non-ecological studies yielded similar results, having similar positive statistically significant
coefficients for the quadratic term (0.21 ˘ 0.03) coefficient, similar negative coefficients for the linear
terms (~0.45 ˘ 0.08), and an excellent goodness-of-fit (Prob > F value) of < 0.01. Both the analysis
of the study populations in the case-control studies and the study population in the cohort study
had quadratic terms with statistically significant positive (~0.17 ˘ 0.02) coefficients, linear terms with
negative (~´0.365 ˘ 0.016) coefficients that was statistically significant only for the cohort study, and
a good goodness-of-fit (Prob > F value) of < 0.05.
All five models have negative coefficients for the linear term, which, for the meta-regression
analysis, for all studies, for the regression and for the cohort study, are statistically significant.
There was more variation (´0.34 to ´0.18) in the coefficients for the linear term than for the
2 accounts for the residual
coefficients for the quadratic terms. The study heterogeneity measure Ires
variation due to heterogeneity not explained by the outcome-covariate associations; it was small
(37%) for the analysis of the ecological studies and was 0% for the other meta-regression analyses
(Not shown). The estimated τ̂ 2 indicates the magnitude of the between study variance and was
also small—0.009 for the all-study analysis, 0.014 for the ecological analysis, and zero for the
non-ecological and case-control analyses [Not shown]. The coefficients from the meta-regressions
and the cohort regression and their 95% confidence intervals are displayed in Figure 3.
The linear coefficients are all seen to be negative and similar, with three out of five being
statistically significantly negative, and the quadratic coefficients are all seen to be positive and similar,
with five out of five being statistically significantly positive. Thus, the standard pattern is an excellent
fit to a no-constant linear-quadratic model with a statistically significant positive coefficient for the
quadratic term and a variably statistically significant negative coefficient for the linear term.
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Linear and Quadratic Coefficients
with 95% Confidence Limits by Study Design

Regression Coefficients
with 95% Confidence Limits

0.8

Linear Coefficients

Quadratic Coefficients

0.6
0.4
0.2
0.0
-0.2
-0.4
-0.6
-0.8
-1.0
-1.2

Figure
Linear and
and quadratic
quadratic coefficients
coefficients by
study design.
design. * Regression
* Regressioncoefficients;
coefficients; others
others
Figure3.3. Linear
by study
meta-regression.

meta-regression.

3.6.4.
X-Intercept
TheZero
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coefficients are all seen to be negative and similar, with three out of five being statistically

significantly
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quadratic
are all
seen to bearsenic
positiveexposure
and similar,
with
out
The Xintercepts
ofand
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models,
i.e.,coefficients
the non-zero
increased
level
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which
Log
RRbeing
= zero
and RR =significantly
1.0, were obtained.
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all-study
populations
analysis
of
five
statistically
positive. Thus,
the the
standard
pattern
is an excellent
fit yielded
to a noa
X
of
136
µg/L.
The
X
for
the
ecological
studies
was
159
µg/L,
while
that
for term
the
intercept
intercept
constant linear-quadratic model with a statistically significant positive coefficient for the quadratic
non-ecological studies was 118 µg/L. The Xintercept for the case-control studies was 98 µg/L, while
and a variably statistically significant negative coefficient for the linear term.

that for the cohort study was 207 µg/L. Each Xintercept was statistically significant with its 95% CI not
including
The interval between 0 and Xintercept can be interpreted as approximately the range of
3.6.4. Zerozero.
X-Intercept
an increased level of arsenic exposure for which the model would not predict an increase in the risk
of The
lung cancer.
Xintercepts of the models, i.e., the non-zero increased arsenic exposure level at which
The data from the studies on arsenic ingestion and lung cancer, grouped by study design,
Log RR
= zero and RR = 1.0, were obtained. Overall, the all-study populations analysis yielded a Xintercept
are each found to fit similar no-constant linear-quadratic log-log meta-regression models. All the
of 136 µg/L. The Xintercept for the ecological studies was 159 µg/L, while that for the non-ecological
meta-regressions show an excellent (p < 0.01) fit to the model with statistically significant positive
studies
was 118
µg/L.
The Xintercept
case-control
studies
was
98 is
µg/L,
whileinthat
formodel
the cohort
coefficients
for the
quadratic
term. for
Thethe
coefficient
for the
linear
term
negative
each
and
study
was
207
µg/L.
Each
X
was
statistically
significant
with
its
95%
CI
not
including
zero.
The
intercept
is statistically significant in the overall model. The regression for the cohort study shows a good
(p < 0.05) fit to the model with a statistically significant positive coefficient for the quadratic term and
also a statistically significant negative coefficient for the linear term. The coefficient for the quadratic
term is similar in all the analyses, and the coefficient for the linear term in the analysis of the cohort
study is more greatly negative than that of the others. The regression results based on the ecological
studies are not different from the results based on the non-ecological studies.
In summary, regression analysis using a no-constant linear-quadratic model with
log-transformed data, both for a pooling analysis and for a meta-regression, finds a general
pattern of excellent fit to the model with a mostly statistically significant negative linear term, an
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always statistical significant positive quadratic term, and a statistically significant Xintercept generally
in the 100 µg/L to 150 µg/L range with an overall Xintercept of 136 µg/L.
4. Discussion
We have reviewed the literature on lung cancer risk and drinking water arsenic exposure
and have performed a set of regression analyses of the data found. We found six studies
whose study population met the study inclusion criteria. As neither the lung cancer risks nor
the arsenic concentrations as a group distributed normally, we performed our analyses applying
the log-transformation to make data normally distributed. A variety of models were examined,
and the data were found to best fit a no-constant linear-quadratic model. Simple regression and
meta-regression analyses were conducted with the data for all study populations and separated by
study design—ecological studies and non-ecological studies, followed by case-control studies and
the cohort study. The ecological studies were mortality studies, and the non-ecological studies were
incidence studies. We found that the fitted models for each group of studies gave similar results.
In general, the goodness-of-fit for the models was good to excellent, with coefficients for the quadratic
terms that were all statistically significant and positive, and coefficients for the linear term that were
uniformly negative and quite frequently statistically significant. Further, each model leads to the
identification of an exposure level (generally about 100–150 µg/L), below which there is, with a range
of uncertainty, no evidence of an increased risk of lung cancer, nor is there evidence of a negative, or
hermetic (J-shaped), response.
Other systematic reviews have excluded ecological studies from their meta-analyses on the basis
that non-ecological (case-control and cohort) studies have stronger or more efficient study designs as
they have individualized data on exposures and confounders [44,45]. In contrast, we have analyzed
the literature for both ecological studies and non-ecological studies. We found that the patterns of the
regression models were the same for both ecological and non-ecological, and that the results of their
meta-regressions were virtually identical. We conclude that the weight of evidence provided by the
ecological studies and by the non-ecological studies are equivalent.
The definition of the study populations, the exposure strata, and the risk estimates generally
followed those of the authors. The exception is that the villages of the Morales et al. (2000) study
group entered the analyses based on the mean village well water arsenic level rather than the
median [40]. The Morales et al. (2000) study was the only one to have a reference exposure that
was not approximately 1–10 µg/L [40]. The all study meta-regression was rerun with the exclusion
of that study and yielded a similar pattern with a Xintercept of 153 µg/L.
As a sensitivity analysis, the meta-regression was run with a variety of inclusion assumptions
and found to yield Xintercepts that ranged between 100 and 165 µg/L. These alternative analyses
included the data from their first publication instead of the data from the most recent presentation
when individual studies were either dropped or used the data from their first publication instead of
the data from the most recent presentation, and when studies were grouped by geographical area,
data source (death certificate vs. medical record/registry), presumed nutritional status, or highest
exposure. The Xintercept , when including studies, were limited to those with exposure > 500 µg/L was
135.6 µg/L.
4.1. Biological Plausibility
Whether arsenic is a “threshold” carcinogen or not has been debated for decades. The U.S. EPA
held a roundtable on this topic in 1995 and reached no conclusion [46]. Later, the U.S. Food and Drug
Administration (U.S. FDA) led a symposium seeking to “explain the apparent non-linear threshold
response for arsenic carcinogenesis” [47]. It was concluded that most modes of action (MOAs)
identified for arsenic carcinogenesis supported a non-linear dose-response at low-level exposures.
Subsequently, studies have focused on mode of action.

15508

Int. J. Environ. Res. Public Health 2015, 12, 15498–15515

Snow et al. (2005) [19] focused on oxidative stress as mode of action but also considered
cellular proliferation or telomerase activation, suggesting a sub-linear dose-response curve].
Schmeisser et al. (2013) [48] focused on mitochondrial transcription factors, a process known
as mitohormesis. Finally, Cohen et al. (2013) [16] provided evidence that the mode of action
involved reactive trivalent metabolites interacting with critical cellular sulfhydryl groups, leading
to cytotoxicity and regenerative cell proliferation. They concluded that the cytotoxicity induced
by inorganic arsenic resulted in non-cancer toxicities, and that the regenerative cell proliferation
enhanced development of epithelial cancers, including those of the lung.
The linear-quadratic models demonstrated here are not inconsistent with current thinking on
these nonlinear MOA processes underlying arsenic carcinogenicity.
4.2. Risk Modeling
There are some limitations with our linear-quadratic model. It was based on the assumption
that a single analytic model would express an exposure-outcome relationship in a continuous model
across the full exposure range. It may be that a segmental model with two segments would fit the
data better, since the biological model proposed (cellular toxicity followed by cellular proliferation)
would not necessitate the same process or dose-response pattern in both exposure ranges. Further
analyses could include the extension of a hockey-stick model or a step function in the meta-regression
framework with a robust estimation of such a hooked pattern using non-parametric regression
approaches. In fact, US EPA (2005) cancer guidelines specifically encourage investigators to
contemplate dual modes of action in any dose response assessment when sufficient data on MOA
and tumor observations are available [49]. Unfortunately, we are unable to distinguish between these
models but propose the continuous model as being most parsimonious. Our judgment here is similar
to that proposed by Dourson et al. (2008) [50] for the dose-response assessment for acrylamide’s
tumorigenicity based on a dual mode of action (MOA), and for similar reasons.
An alternative interpretation of our model might be that the ingestion of inorganic arsenic
stimulates both anti-carcinogenic responses (linear and negative) and pro-carcinogenic responses
(quadratic and positive). At some exposure levels, the pro-carcinogenic responses would be greater
than the anti-carcinogenic response, leading to the observed effects. Additional efforts would need to
be made to explore this speculation and seek a mechanistic basis.
4.3. Limitations
These analyses are able to assess the overarching hypothesis on the shape of the dose-response
curve for lung cancer over the range of low to high water arsenic concentration exposures. They are
not able to distinguish difference in risk or risk pattern for males vs. females or for smokers vs.
non-smokers. Other sources of arsenic exposure, such as dietary or occupational, have not been
included. These analyses intrinsically have assumed that within each study the daily water intake is
independent of the arsenic water concentration, though the population water consumption may differ
between studies. Most of these study populations have been nutritionally sufficient, and issues of
nutritional deficiency and arsenic metabolism are also not included. As it is based on the studies that
cover the full exposure range, it has not included those studies that are limited to the low exposure
range. Further, these analyses apply only to the carcinogenic risk pattern for lung cancer and not for
other adverse effects of inorganic arsenic ingestion, such as cardiovascular, endocrine/metabolic, and
reproductive aspects. The carcinogenic risk pattern for bladder cancer has been assessed elsewhere
(Tsuji et al., 2014) [45].
5. Conclusions
We have conducted a systematic review of the epidemiological literature on drinking water
arsenic levels and lung cancer and an analysis of their data. We examined the fit to a wide range
of continuous models and found overall, and by study design, that the lung cancer data best fit a
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linear-quadratic model with a statistically significant positive quadratic coefficient and a negative
linear coefficient that was statistically significant in the overall model. Importantly, we found that
an analysis of the data from the ecological studies was as informative and with similar results as an
analysis of the data from the non-ecological studies (i.e., case-control and cohort studies). All analyses
yielded statistically significant Xintercepts that generally indicate no increased risk at exposures below
about 100–150 µg/L for lung cancer over the low through high arsenic exposure range.
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Appendix
Description of Studies and Available Data
Summaries of the studies’ contributing data to the systematic review follow with a presentation
of their data options for exposure and for risk of outcome. The exposure data in bold indicate the
exposure data used in the systematic review. The risk statements include 95% confidence intervals
when available. Case/Cont indicates the number of cases and controls within the specific stratum in
the case-control studies.
Ecological Studies
Ferreccio et al. (2006) [38] reviewed studies on the health impact of arsenic exposure in Chile.
With regard to lung cancer, they reported the SMRs for 1985–1992 and 1993–2002 for four cities with
different levels of arsenic exposure. The authors presented the average exposures for each city from
1958 to 1970, though for some cities the highest exposures were from 1971 to 1977. They presented
SMRs for males and females combined, based on Chilean national data. Our analyses were based on
the higher of the 1958–1970 and 1971–1977 exposures.
City
Valparaiso
Calama
Tocopilla
Antofagasta

1958–1970
<10
150
250
860

Arsenic
1971–1977
Highest
<10
<10
287
287
636
636
110
860

1985–1992
136.6
140.7
479.1
420.1

SMR
1993–2002
131.8
112.5
497.2
406.1

RR
1985–2002
133.9
125.0
433.6
412.3

1985–1992
1.00
1.03
3.51
3.08

1993–2002
1.00
0.85
3.01
3.08

1985–2002
1.00
0.93
3.51
3.08

Morales et al. (2000) [40] is an analysis of the 42 village study population in the arsenic endemic
region of southwest Taiwan (Wu et al. 1989) [5]. The regional data served as the reference population.
Drinking water samples were taken from 1964 to 1966 from extant wells in 42 villages. Cancer
mortality data for 1973–1986 came from death certificates. Wu et al. (1989) [5] had reported a
stratified analysis based on median village well water arsenic levels in three strata (<300, 300–600,
and > 600 µg/L), and Morales et al. (2000) [40] reported the same for adults in eight strata
(0–50, 50–100, 100–200, 200–300, 300–400, 400–500, 500–600, and 600+ µg/L). NRC (1999) [43]
published a table of well water levels and cancer counts for each village among adults aged 20 y/o or
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older. Those data revealed that the use of the median led to misclassification errors as some villages
with low level medians (10–126 µg/L) had very high exposures (580–770 µg/L) that were not reflected
in the medians. We have used the arsenic strata of Morales et al. (2000) [40] but have entered the
villages on the basis of their means rather than their medians. Within each stratum, we have given
both the median mean and the population-weighted mean and have used the population-weighted
means for each strata.
Arsenic
0–50
50–100
100–200
200–300
300–400
400–500
500–600
600–818

Mid-Range
25
75
150
250
350
450
550
767

Median Mean
32
62.5
122.5
245.9
328.5
448
529
665.2

Pop-Wt Mean
33.1
66.3
115.2
246.3
336.3
446.7
524.4
693.9

SMR
1.80 (1.11–2.75)
1.47 (0.97–2.14)
1.64 (0.82–2.94)
4.10 (3.01–5.44)
2.34 (1.21–3.84)
4.31 (2.67–6.59)
3.65 (2.53–5.10)
5.59 (4.51–6.84)

RR
1.00
0.82
0.91
2.28
1.30
2.40
2.03
3.11

Case-control Studies
Dauphine et al. (2013) [41] studied histologically-confirmed lung cancer cases diagnosed in
2002–2005 and controls from six counties in western Nevada and one (Kings County) in central
California. Over 7000 arsenic measurements from public drinking water sources and private wells
were obtained from the state health departments. Arsenic levels have been shown to be relatively
stable over time in the area. If a measurement for a well was unavailable, the median of all wells
within the same square-mile had been used. Individuals were stratified by their highest 5-year
average arsenic exposure after a 40 year lag into ď10 µg/L, 11–84 µg/L, and ě85 µg/L. Exposure
data for 30 of the 54 in the high group were reported as a mean of 173 µg/L, a median of 110 µg/L,
and a mode (24/30) of 110 µg/L. Lung cancer cases (N = 196) were identified directly from hospitals.
Cases had to be >25 years old, living in the study area at the time of diagnosis, and able to provide
interview data. Controls (N = 359) were selected by random digit dialing and matched by age, gender,
and state but not county. Adjusted and unadjusted odds ratios differed little. Mid-range levels were
used in the analyses for the lower strata, and the mode was used for the high exposure group.
Arsenic
ď10
11–84
ě85

Mid-Range
5
42.5
772.5

Median

Mean

110

173

Case-control
141/241
37/82
18/36

OR
1.00
0.77
0.85

Adj OR
1.00
0.75
0.84

Ferreccio et al. (2013) [39] studied lung cancer cases diagnosed between 2007 and 2010
and controls from the 922,579-person population of Regions I and II of northern Chile. Arsenic
measurements were available for >97 % of all drinking water sources in the area. Exposure levels were
determined for each city and town and presented for seven time intervals between 1930 and 1995 (+).
The exposure levels ranged from a high of 860 µg/L for Antofagasta and Mejillones between the years
1958 and 1970 to a low of 10 µg/L or less in Arica and Putre. The authors stratified the exposure into
four groups, based on the four largest cities in the study area: Arica (10 µg/L), Iquique (60 µg/L),
Calama (150 µg/L in 1958–1970; 287 µg/L in 1971–1977), and Antofagasta (860 µg/L in 1958–1970;
110 µg/L in 1971–1977). Each individual’s exposure was defined as their highest single-year exposure
throughout the subject's lifetime, from birth to diagnosis or entry into study. Cases (N = 306) were
obtained from pathologists, hospitals, and radiologists. Inclusion criteria for cases were lung cancer
diagnosis from 2007 to 2010, resident in the study area, >25 years old, and provided interview data.
Controls (N = 640) were randomly selected from electoral registries and matched by age and gender.
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The authors used as the exposure metric the highest level for the largest city in the strata, which was
reasonable for three of the four strata. For the third stratum (200 µg/L–799 µg/L), the highest level
in the largest city (Calama) was 287 µg/L, while the highest levels in the other cities in that stratum
were 600 µg/L and 636 µg/L. The other cities contained 26% of the population of that stratum. The
population-weighted mean for the third stratum was 377.5 µg/L, which we used in our analysis.
Arsenic
0–59
60–199
200–799
ě800

Mid-Range
30
130
500
900

Largest City
10
60
287
860

Pop-Wt Mean
10.2
60
377.5
860

Case/Cont
48/138
52/193
69/144
137/165

OR
1.00
0.77
1.38
2.39

Smith et al. (2009) [20] reported a re-analysis of data from his team’s previously published
case-control study (Ferreccio et al., 2000) [51]. This case-control study had compared arsenic exposures
of lung cancer cases diagnosed in 1994–1996 and their controls also in regions I, II, III in northern
Chile. Ferreccio et al. (2000) [51] presented in Table 1 the arsenic exposure for the various towns
and cities in the study area for six time intervals between 1930 and 1994. Arsenic concentrations since
1930 have generally remained steady, with the exceptions that two cities (Antofagasta and Mejillones)
had a marked increase from 1958 to 1970 and three cities (Tocopilla, Maria Elena, and Calama) had a
marked increase from 1971 to 1977. The arsenic concentrations in Antofagasto and Mejillones were
860 µg/L during 1958–1970 and 90 µg/L before and 110 µg/L afterwards. The arsenic concentrations
in Tocopilla and Maria Elena were 636 µg/L during 1971–1977 and 250 µg/L before and 110 µg/L
afterwards. The arsenic concentrations in Calama were 287 µg/L during 1971–1977 and 150 µg/L
before and 110 µg/L after. Smith et al. (2009) [20] and Ferreccio et al. (2000) [51] analyzed risk in
relation to 1958–1970 exposures. We analyzed risk in relation to population-weighted averages using
the higher of either the 1958–1970 or 1971–1977 exposure levels.

Arsenic
0–9
10–59
60–199
200–399
400–699
700–999

Mid-Range
5
35
130
300
550
850

(58–70)
1.0
12.8
97.3
250
600
860

Pop-Wt
(71–77)
1.0
12.8
154
636
600
110

Highest
1.0
12.8
154
636
600
860

Case/Cont
11/92
7/81
35/87
23/44
11/12
64/103

Adj OR
1
0.7
3.4
4.7
5.7
7.1

Cohort Study
Bogen et al. (2014) [21] presented a re-analysis by C.L. Chen of the Chen et al. (2010) [52] study
of four townships in the arseniasis-endemic area on the northeastern coast of Taiwan. Residents
(n = 8102) had used wells in their own backyards from the 1940s until tap water was implemented in
the 1990s. Well water samples collected at the time of interview in 1991–1994 had levels of <0.15 to
3590 µg/L arsenic. Well use histories were obtained. Full exposure histories could be developed
for a cohort of 6888 members aged > 40 y/o. Lung cancer cases newly diagnosed from 1991 to
2006 were identified through Taiwan's national cancer registry. The Chen et al. (2010) [52] analysis
had assigned subjects by their arsenic level at their time of enrollment into four arsenic exposure
strata (<10, 10–49.9, 50–99.9, 100–299.9, and ě 300 µg/L). Subsequently, Chen released a five-stratum
analysis (0–1, 1–<10, 10–<50, 50–<100, 100–<300, and ě 300 µg/L) with arithmetic mean arsenic levels
and relative risks (Bogen, Chen, and Tsuji, 2014) [21].
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Range
0–1
1<10
10–<50
50–<100
100–<300
>300

Mean
1
3.26
25.9
74.3
160
711

Participants
1071
1371
2027
880
873
666

Person-Years
12,558
15,781
23,473
9989
10,000
7525

Cases
32
23
47
19
27
30

adj RR
1.00
0.57
0.73
0.68
1.08
1.57
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